Halozyme's ENHANZE® Technology with Takeda's HYQVIA® for CIDP
Drug Updates

Halozyme Announces Takeda Received European Commission Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin Infusion 10% (Human)] co-formulated with Halozyme’s ENHANZE® drug delivery technology as maintenance therapy in patients of all ages with chronic inflammatory demyelinating polyneuropathy (CIDP) after stabilization with intravenous immunoglobulin therapy (IVIG). HYQVIA® also recently received U.S. Food and Drug Administration […]

Insightec MR-guided Focused Ultrasound Treatment
Device Digest

INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSENTIAL TREMOR

Insightec, a pioneer and global leader in focused ultrasound, has welcomed a positive recommendation report[1] from the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) to have MR-guided focused ultrasound (MRgFUS) reimbursed for people suffering from essential tremor (ET). This recommendation is a pivotal moment, paving the way for nation-wide access to focused ultrasound treatment for essential tremor. […]

Tarsier Pharma TRS01: FDA Approves Uveitis Treatment
Drug Updates

Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01 in Noninfectious Uveitis

Tarsier Pharma, Ltd., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for the treatment of blinding ocular diseases, today announced the successful outcome of a Type C meeting with the U.S. Food and Drug Administration (FDA), supporting the advancement of TRS01 eye drop formulation for the treatment of noninfectious uveitis […]

Kate Moss and Deepak Chopra Together
Mental Wellness

COSMOSS Partners With Chopra Foundation ‘Never Alone’ to Support Mental Health Awareness

Kate Moss, Founder of COSMOSS, and Deepak Chopra, Founder of Chopra Foundation, are proud to announce a new partnership to support mental health and wellbeing between COSMOSS and the Chopra Foundation. From January 2024, COSMOSS, the Award-Winning Wellness brand by Kate Moss, will be working with Chopra Foundation to support wellness and mental health programmes […]

Tampa General Hospital Exterior
Hospital Updates

Tampa General Hospital Named One of Newsweek’s Best Smart Hospitals for 2024

Tampa General Hospital (TGH) has been recognized as one of the World’s Best Smart Hospitals for 2024 by Newsweek and Statista. This prestigious global accolade is a testament to Tampa General’s commitment to harnessing cutting-edge technology to enable world-class patient care, improve care coordination and streamline hospital operations. “As a leading academic health system, driving […]

MGI Gencell Partnership Illustration
Device Digest

MGI Partners with Gencell to Expand Genomics in Latin America

MGI, a company committed to building core tools and technology to lead life science, is thrilled to announce a strategic partnership with Gencell, a health company focused on molecular biology and genetic services in Colombia and the broader LATAM region. This collaboration capitalizes on the expertise and established market presence of Gencell and integrates MGI’s […]

AI in Drug Discovery Illustration
Drug Updates

Unlocking the Future of Drug Discovery with Artificial Intelligence

BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the AI-driven revolution in drug discovery. BOSTON, Sept. 22, 2023 /PRNewswire/ — The report highlights a […]

Astellas Pharma and Seagen Logos
Drug Updates

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced positive topline results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for PADCEV® (enfortumab vedotin-ejfv) in combination with KEYTRUDA® (pembrolizumab) versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (la/mUC), a […]

NYU Langone Health Logo
Hospital Updates

NYU Langone Health ranked No. 1 in the Nation for Quality and Patient Safety

NYU Langone Health has once again been named No. 1 in the nation for quality and patient safety by Vizient, Inc., a leading healthcare performance improvement organization that determines its rankings based on mortality and infection rates, patient experience scores, and other critical quality measures. At a ceremony hosted by Vizient in Las Vegas last […]

GC FLU Quadrivalent Pre-filled syringe inj. - Approved by Egyptian Drug Authority
Device Digest

GC Biopharma’s “GC FLU” obtains vaccine approval in Egypt: First-ever approval of the company’s quadrivalent flu vaccine on the African continent

GC Biopharma, a South Korean biopharmaceutical company, announced on the 18th that its quadrivalent flu vaccine called GC FLU Quadrivalent Pre-filled syringe inj. has been approved by the Egyptian Drug Authority. This is the first approval the company has obtained on its quadrivalent flu vaccine on the African continent. Egypt has one of the largest […]